GlaxoSmithKline invests 275 million pounds in UK despite Brexit vote

LONDON (Reuters) - GlaxoSmithKline plans 275 million pounds of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month's vote to leave the European Union.

from Reuters: Top News http://uk.reuters.com/article/uk-gsk-britain-idUKKCN1070HY?feedType=RSS&feedName=topNews